Skip to main content

Advertisement

SpringerLink
Log in

Endocrine Therapy Plus Zoledronic Acid in Premenopausal Breast Cancer: Review of a Clinical Trial

  • Clinical Trial Report
  • Published:
Current Breast Cancer Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Coleman RE, Thorpe HC, Cameron D, et al: Adjuvant treatment with zoledronic acid in stage II/III breast cancer. The AZURE Trial (BIG 01/04). Program and abstracts of the 33rd Annual San Antonio Breast Cancer Symposium; December 8-12, 2010; San Antonio, Texas. Abstract S4-5

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Mater Misericordiae University Hospital, Eccles St, Dublin 7, Ireland

    Catherine M. Kelly

  2. Department of Medical Oncology, Albert Einstein/Montefiore Medical Center, 1825 Eastchester Road, Bronx, NY, 10461, USA

    Eleni Andreopoulou

Authors
  1. Catherine M. Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eleni Andreopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eleni Andreopoulou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kelly, C.M., Andreopoulou, E. Endocrine Therapy Plus Zoledronic Acid in Premenopausal Breast Cancer: Review of a Clinical Trial. Curr Breast Cancer Rep 3, 4–5 (2011). https://doi.org/10.1007/s12609-010-0035-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12609-010-0035-z

Keywords

Search

Navigation